The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinomaManfred Johannsen, Filippo de Braud, Gianluca Spitaleri et al.|European Journal of Cancer|2010Cited by 187
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factorsPietro Iaffaldano, Vincenzo Brescia Morra, Giovanna De Luca et al.|Multiple Sclerosis Journal|2020Cited by 32